Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Connect Biopharma Limite...

    NASDAQ: CNTB · Real-Time Price · USD
    0.98
    0.03 (3.16%)
    At close: Jun 16, 2025, 3:58 PM
    0.94
    -4.07%
    After-hours: Jun 16, 2025, 07:57 PM EDT

    Connect Biopharma Statistics

    Share Statistics

    Connect Biopharma has 55.35M shares outstanding. The number of shares has increased by 0.27% in one year.

    Shares Outstanding

    n/a
    		 55.35M

    Shares Change (YoY)

    n/a
    		 0.27%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 5.77%

    Shares Floating

    n/a
    		 14.32M

    Failed to Deliver (FTD) Shares

    n/a
    		 3,813

    FTD / Avg. Volume

    n/a
    		 2.9%

    Short Selling Information

    The latest short interest is 61.37K, so 0.11% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 61.37K

    Short % of Shares Out

    n/a
    		 0.11%

    Short % of Float

    n/a
    		 0.17%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -4.88 and the forward PE ratio is -0.15. Connect Biopharma's PEG ratio is 0.07.

    PE Ratio

    n/a
    		 -4.88

    Forward PE

    n/a
    		 -0.15

    PS Ratio

    n/a
    		 2.93

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 0.83

    P/FCF Ratio

    n/a
    		 -3.13

    PEG Ratio

    n/a
    		 0.07
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Connect Biopharma.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 11.46, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 11.46

    Quick Ratio

    n/a
    		 11.46

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 -0.01

    Debt / FCF

    n/a
    		 -0.01

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $419,887.1

    Profits Per Employee

    n/a
    		 $-252,064.52

    Employee Count

    n/a
    		 62

    Asset Turnover

    n/a
    		 0.26

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 223K

    Effective Tax Rate

    n/a
    		 -1.45%

    Stock Price Statistics

    The stock price has increased by -40.61% in the last 52 weeks. The beta is -0.27, so Connect Biopharma's price volatility has been lower than the market average.

    Beta

    n/a
    		 -0.27

    52-Week Price Change

    n/a
    		 -40.61%

    50-Day Moving Average

    n/a
    		 0.77

    200-Day Moving Average

    n/a
    		 0.99

    Relative Strength Index (RSI)

    n/a
    		 71.16

    Average Volume (20 Days)

    n/a
    		 131,709

    Income Statement

    In the last 12 months, Connect Biopharma had revenue of 26.03M and earned -15.63M in profits. Earnings per share was -0.28.

    Revenue

    n/a
    		 26.03M

    Gross Profit

    n/a
    		 25.37M

    Operating Income

    n/a
    		 -22.45M

    Net Income

    n/a
    		 -15.63M

    EBITDA

    n/a
    		 -22.45M

    EBIT

    n/a
    		 -22.45M

    Earnings Per Share (EPS)

    n/a
    		 -0.28
    Full Income Statement

    Balance Sheet

    The company has 78.23M in cash and 178K in debt, giving a net cash position of 78.05M.

    Cash & Cash Equivalents

    n/a
    		 78.23M

    Total Debt

    n/a
    		 178K

    Net Cash

    n/a
    		 78.05M

    Retained Earnings

    n/a
    		 -345.36M

    Total Assets

    n/a
    		 101.28M

    Working Capital

    n/a
    		 88.5M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -23.61M and capital expenditures -750K, giving a free cash flow of -24.36M.

    Operating Cash Flow

    n/a
    		 -23.61M

    Capital Expenditures

    n/a
    		 -750K

    Free Cash Flow

    n/a
    		 -24.36M

    FCF Per Share

    n/a
    		 -0.44
    Full Cash Flow Statement

    Margins

    Gross margin is 97.46%, with operating and profit margins of -86.24% and -60.03%.

    Gross Margin

    n/a
    		 97.46%

    Operating Margin

    n/a
    		 -86.24%

    Pretax Margin

    n/a
    		 -59.17%

    Profit Margin

    n/a
    		 -60.03%

    EBITDA Margin

    n/a
    		 -86.24%

    EBIT Margin

    n/a
    		 -86.24%

    FCF Margin

    n/a
    		 -93.58%

    Dividends & Yields

    CNTB does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for CNTB is $7, which is 614.3% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $7

    Price Target Difference

    n/a
    		 614.3%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -3.06

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist